Particularly in tumor cells, mitochondrial ERK activation is sustained by selective MAP oxidation and desensitizes the permeability transition pore [30], which constitutes a possible mechanistic basis for the contribution to a tumor phenotype and increased resistance to apoptosis of neoplasic cells. The gene discussed is MAPK1; the disease is neoplasm.